Sree Rayalaseema Hi-Strength Hypo Limited
NSE: SRHHYPOLTDMarket Closed • NSE
Day range
52 week range
Sree Rayalaseema Hi-Strength Hypo Limited closed at INR533.85 (-0.17%) on volume 0.25x its 20-day average, trading 20.32% below its 52-week high.
2026-Q2
Q2 FY2026 Financial Results
PAT moved +25% QoQ
2026-09-18
DIVIDEND Announced
Dividend - Rs 3 Per Share
2025-09-19
DIVIDEND Announced
Dividend - Rs 3 Per Share
Revenue and PAT bars use independent scales to make their year-on-year direction readable.
Complete reported financial history · Values use the company's reporting currency
Hover over the chart for exact reported values. Percentage lines use the right-hand axis.
A 0–100 quantitative summary of reported fundamentals. Use the underlying financials and risks for context; the score is not a buy or sell recommendation.
Strengths
Attractive Valuation: P/E of 9.9x trades below sector historical averages
Risks
Subject to cyclical raw material and macro industry pressures
Bull case
Market Leadership: Established operational scale in Chemicals.
Bear case
Macro Headwinds: Fluctuations in interest rates and sector-specific policy shifts could compress multiples.
Flip condition
Sustained quarterly EBITDA margin expansion above 20% would trigger an upgrade.
Ownership distribution
Category trends
Hover over a period for exact holdings
Complete dividend, bonus, split, rights and other action history
| Record date | Corporate action | Information | Announcement date | Ex-date |
|---|---|---|---|---|
| 18 Sept 2026 | Dividend | ₹3.00 / share | — | 18 Sept 2026 |
| 19 Sept 2025 | Dividend | ₹3.00 / share | — | 19 Sept 2025 |
| — | Dividend | ₹3.00 / share | — | 12 Sept 2024 |
| — | Dividend | ₹4.00 / share | — | 18 Sept 2023 |
| — | Dividend | ₹3.50 / share | — | 21 Sept 2022 |
| — | Dividend | ₹3.00 / share | — | 22 Sept 2021 |
| — | Dividend | ₹2.50 / share | — | 20 Nov 2020 |
| — | Dividend | ₹2.00 / share | — | 20 Sept 2019 |
| — | Dividend | ₹2.00 / share | — | 19 Sept 2018 |
| — | Dividend | ₹1.50 / share | — | 19 Sept 2017 |
| — | Dividend | ₹1.50 / share | — | 20 Sept 2016 |
| — | Dividend | ₹1.50 / share | — | 22 Sept 2015 |
Traded volume and delivery percentage across the latest 20 sessions
Compare valuation, latest quarterly performance and year-on-year growth
| Company name | Market cap ₹ Cr | P/E ratio | Dividend yield % | Quarterly sales ₹ Cr | Profit after tax ₹ Cr | Sales growth % | Profit growth % |
|---|---|---|---|---|---|---|---|
 UltraTech Cement LimitedULTRACEMCO Open analysis | ₹3.14L | 36.80 | 2.30% | ₹25,799.47 | ₹2,982.76 | +11.86% | +20.17% |
 JSW Steel LimitedJSWSTEEL Open analysis | ₹2.85L | 11.52 | 0.60% | ₹47,364.00 | ₹4,651.00 | +11.55% | +112.96% |
 Hindustan Zinc LimitedHINDZINC Open analysis | ₹2.30L | 13.46 | 2.07% | ₹13,687.00 | ₹5,425.00 | +77.22% | +146.14% |
 Asian Paints LimitedASIANPAINT Open analysis | ₹2.24L | 47.08 | 1.19% | ₹10,541.94 | ₹1,539.25 | +17.94% | +39.96% |
 Tata Steel LimitedTATASTEEL Open analysis | ₹2.17L | 19.64 | 2.33% | ₹60,794.00 | ₹2,385.00 | +14.32% | +18.83% |
 Hindalco Industries LimitedHINDALCO Open analysis | ₹2.00L | 12.21 | 0.56% | ₹84,825.00 | ₹7,013.00 | +32.06% | +75.15% |
 Grasim Industries LimitedGRASIM Open analysis | ₹1.96L | 34.47 | 0.35% | ₹11,794.71 | ₹246.65 | -70.60% | -82.61% |
 Solar Industries India LimitedSOLARINDS Open analysis | ₹1.81L | 90.88 | 0.06% | ₹3,668.00 | ₹666.00 | +70.29% | +88.67% |
Incorporated in 2005, Sree Rayalaseema Hi – Strength Hypo Ltd is a producer of producer of Calcium Hypo -chloride, Stable Bleaching Powder, Sulphuric Acid and other chemicals[1]
IndiaBasic Materials
Is Sree Rayalaseema Hi-Strength Hypo Limited Shariah compliant?
Sree Rayalaseema Hi-Strength Hypo Limited is currently screened as Shariah Compliant under AAOIFI Shariah Standard No. 21. Business activities align with Shariah permissible sectors. Debt to Market Cap (1.27%) complies with AAOIFI threshold (≤ 33%).
What is Sree Rayalaseema Hi-Strength Hypo Limited's current valuation relative to peers?
Sree Rayalaseema Hi-Strength Hypo Limited trades at a P/E of 9.9x compared to the sector median of 21.4x, and a Price-to-Book of 0.9x.
Is the company financially healthy?
The company has a Debt-to-Equity ratio of 1.18x. Interest coverage is 48.4x.
What are the historical revenue and profit growth rates?
Over the past 5 years, revenue compounded at -5% while net profit growth averaged 2.7%.
Market data is informational and may be delayed. Shariah screening follows the displayed methodology. This is not investment advice.
Market data may be delayed. Quote date: 2026-10-09. Financial figures relate to their stated reporting periods. This information is for research and is not a recommendation to buy or sell.